A pioneering AI-led cognitive assessment which can lead to early-stage detection of dementia has partnered with an NHS Mental Health Trust to implement its technology into both primary and secondary care.
Cognetivity Neurosciences will see its Integrated Cognitive Assessment (ICA) used by Birmingham and Solihull Mental Health NHS Foundation Trust (BSMHFT), which operates from over 40 sites across the West Midlands to serve a population of more than 1.3million patients.
In its latest NHS deployment, fast-growing Cognetivity’s ICA will be implemented to enhance multiple stages of Birmingham and Solihull’s dementia care pathway.
The deployment will cover secondary care, supporting the specialist diagnostic process and providing long-term monitoring capability, as well as primary care, enabling earlier detection and improved referral rates.
The ICA is able to drive efficiency gains in dementia assessment on account of its unique and computerised approach to cognitive testing.
It offers numerous advantages over traditional pen-and-paper examinations, including a short testing duration, automatic marking and high classification accuracy. It also benefits from the absence of a learning effect and any cultural bias, which is of particular importance in highly diverse populations such as that of BSMHFT.
The partnership with BSMHFT comes after a period of strong growth for Cognetivity in its roll-out, having also recently taken its first steps into the US and Canadian healthcare markets.
The ICA’s introduction will be facilitated by Cognetivity’s partnership with data and interoperability platform provider InterSystems, which already supports BSMHFT’s system of electronic health records (EHRs).
“We’re really excited by the ICA and what it can do for our dementia assessment services,” said Derek Tobin, associate director at BSMHFT.
“We always strive to deliver better value and improved outcomes for our patients, and I am confident that Cognetivity’s technology will help us to do that in this area. I greatly look forward to seeing it at work in the hands of clinicians and patients.”
Dr Sina Habibi, Cognetivity’s CEO, said: “This is wonderful news. We feel honoured that the ICA is being deployed at one of the UK’s best and biggest mental health Trusts, touching the lives of a very large number of patients.
“Of course, it is a very welcome announcement as we continue our commercial rollout throughout the UK and internationally.”
